Key FDA Decisions and Trial Results Expected in October
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
All Work
Chris Lange
Darden Rises on Solid Earnings
Darden Restaurants reported mixed fiscal first-quarter financial results before the markets opened on Tuesday.
Jaguar Animal Health Stumbles on Secondary Offering
Jaguar Animal Health Inc. (NASDAQ: JAGX) filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. The expected price of the 4.32 million shares is $1.20 per share. The…
Mammoth Energy Services Announces Potential Pricing for IPO
Mammoth Energy Services intends to price more than 7 million shares in the range of $15 to $18 per share for an initial public offering valued up to nearly $165 million.
What to Expect From Darden Earnings
Darden Restaurants is scheduled to report its fiscal first-quarter earnings results before the markets open on Tuesday.
Can Micron Keep Up This Growth Through Q4 and Beyond?
Micron Technology is scheduled to release its fiscal fourth-quarter financial results after the markets close on Tuesday.
Tetra Tech Receives $400 Million Contract From US Department of Energy
Tetra Tech has had a good run of 2016 so far, and things could get even better with its new contract from the U.S. Department of Energy.
Shopify Moves to Acquire Boltmade
Shares of Shopify saw a handy gain early on Monday after the company announced that it will be acquiring privately held Boltmade.
Are Cabela’s Shareholders Getting Enough out of the Acquisition?
Cabela’s shares made a handy gain on Monday after it was announced that Bass Pro Shops would be acquiring the company.
Top 5 Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Micron Technology, Monsanto and some of the others notable companies reporting their quarterly results this week.
5 Companies That Destroyed Shareholders Last Week
There are some companies hitting lows and creating huge shareholder losses while the market is just below all-time highs. These are the same companies holding back the market and destroying shareholders.
Top 6 Biopharma Gainers of the Past Week
Over the past week, a few biotech companies made absolutely massive runs. The companies 24/7 Wall St. has picked stood out from the rest with at least 25% gains.
Nutanix Enters the Market With a Bang
Nutanix entered the market with a bang. The company priced its 14 million shares at $16, above the expected pricing range, but the stock actually entered the market above $26 a share.
Och-Ziff Settles With SEC Over Bribery Charges
The SEC has announced that Och-Ziff Capital Management has agreed to pay nearly $200 million to settle civil charges of violating the Foreign Corrupt Practices Act.
Lexmark Receives CFIUS Approval for China Deal
Shares of Lexmark International jumped on the news that it received approval from the Committee on Foreign Investment in the United States for its Apex deal.
CalAmp Stumbles Over Earnings
CalAmp shares tumbled early on Friday after it released its fiscal second-quarter financial results late on Thursday.
SEC Issues Charges Over Biotech Insider Activity
The SEC has charged the former senior director of regulatory affairs for Puma Biotechnology with insider trading ahead of the company’s news announcements about its drug to treat breast cancer.
SEC Fines Gaming Company for Retaliating Against Whistleblower
International Game Technology has agreed to pay a half-million dollar penalty for firing an employee because he reported to the SEC that the company's financial statements might be distorted.
Catabasis Skyrockets on Sarepta Partnership
Catabasis Pharmaceuticals shares skyrocketed on Thursday following an announcement that it would be partnering with Sarepta Therapeutics for a joint research collaboration.
Alcobra Tumbles on FDA Clinical Hold
Alcobra saw its shares get halved on Thursday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on its late-stage trial.